EGFR and non-small cell lung carcinoma: Given that dysregulation of glucose metabolism contributes to CSE-mediated resistance of EGFRWT NSCLC to EGFR TKI (Fig. 1), we further expanded on the role of suppressing glucose metabolism on the antiproliferative activities of these drugs.